Quantcast
Last updated on April 18, 2014 at 11:27 EDT

Latest Gynecologic oncology Stories

2012-03-26 02:26:25

AUSTIN, Texas, March 26, 2012 /PRNewswire-USNewswire/ -- Nobel Prize winner Harald zur Hausen called for vaccinating both young males and females for human papilloma virus (HPV) in an achievable quest to eradicate cervical cancer, which is the second leading type of women's cancer worldwide. Zur Hausen made his remarks at a gathering of more than 1,600 members of the Society of Gynecologic Oncology during its 43rd Annual Meeting on Women's Cancer®( )in Austin. "If we wish to...

2012-03-21 21:26:26

Low bone density medications, such as Fosamax, Boniva and Actonel, may have a protective effect for endometrial cancer, according to a study at Henry Ford Hospital. Endometrial cancer affects more than 45,000 women a year in the U.S., usually in their 60s, although it can occur before 40. A type of uterine cancer, it's the most commonly diagnosed gynecologic cancer, and there is no known preventive medication for women at high risk of developing it. "The results of the study suggest...

2012-02-02 10:00:00

CHICAGO, Feb. 2, 2012 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncology (SGO) will host its 43rd Annual Meeting on Women's Cancer® March 24-27, 2012, at the Austin Convention Center, Austin, TX. The meeting's featured keynote speaker is Harald zur Hausen, who was awarded the Nobel Prize in Medicine for his pioneering discovery of the role of human papilloma virus (HPV) in the development of cancer of the cervix. He currently is professor emeritus, after having...

2012-01-20 10:31:00

CLEVELAND, Jan. 20, 2012 /PRNewswire/ -- Patients with gynecologic cancer have new hope in a novel technology now offered at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center. A team of cancer specialists, led by Robert DeBernardo, MD, is among the first in the nation to launch a dedicated program using Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat ovarian, endometrial and select other cancers. Performed immediately following surgery,...

2012-01-18 20:02:50

Abnormal bleeding can be an early warning sign of cervical cancer and should not be ignored, said a gynecologic oncologist from Baylor College of Medicine. "January marks National Cervical Cancer Awareness Month and is a great time for women of all ages to be aware of common symptoms and early warning signs of the disease," said Dr. M. Yvette Williams-Brown, assistant professor of obstetrics and gynecology at BCM. "All women should know what constitutes abnormal bleeding." When caught...

2011-12-05 17:56:00

IRVINE, Calif., Dec. 5, 2011 /PRNewswire/ -- OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that it has completed a major Licensing and Collaboration Agreement with The Moffitt Cancer Center, the only National Cancer Institute (NCI) Comprehensive Cancer Center in Florida. The agreement provides OvaGene with exclusive worldwide rights to develop and...

2011-11-01 08:30:00

TSX Venture: QPT EDMONTON, Nov. 1, 2011 /PRNewswire/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced that it will be making a presentation at the 2(nd) Biennial Meeting of the Asian Society of Gynecologic Oncology, in Seoul, South Korea, November 3-5. The presentation, entitled "Targeting Dendritic Cells to Create a More Powerful Immune Response: A New...

2011-09-21 11:42:00

WASHINGTON, Sept. 21, 2011 /PRNewswire/ -- September is Gynecologic Cancer Awareness Month (GCAM) and the Foundation for Women's Cancer (formerly the Gynecologic Cancer Foundation) celebrates its 20th anniversary this year with an educational campaign to help women of all ages across the country LEARN how to prevent and detect women's cancers, LISTEN for common body symptoms, and ACT quickly to seek care from a gynecologic oncologist if she suspects or has been diagnosed with a...

2011-09-19 13:01:00

IRVINE, Calif., Sept. 19, 2011 /PRNewswire/ -- OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that the company has received Clinical Laboratory Improvement Act (CLIA) certification for their newly constructed state-of-the-art molecular diagnostics laboratory. The OvaGene laboratory is now fully-licensed to receive patient clinical specimens from...

2011-09-14 07:30:00

AUSTIN, Tex., Sept. 14, 2011 /PRNewswire/ -- Fred Ueland, M.D., Associate Professor of Gynecologic Oncology at the University of Kentucky's Markey Cancer Center, and principal investigator of the multi-center OVA1 clinical trial, today presented data demonstrating the improvement in sensitivity when using imaging in conjunction with OVA1. These data were highlighted at the 17th Annual European Society of Gynecologic Oncology (ESGO) meeting being held in Milan from September 11th to 14th....